We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue

Download Mobile App




In Other News

Image: ASTar is a fully automated instrument designed to produce rapid phenotypic antibiotic susceptibility testing (AST) results directly from positive blood cultures in approximately six hours (photo courtesy of Q-Linea AB)

Rapid Blood-Culture Susceptibility Panel Expands Coverage for Gram-Negative Infections

Gram-negative bloodstream infections and sepsis demand fast, precise antimicrobial therapy, yet conventional susceptibility workflows can delay targeted treatment. Read more
21 Apr 2026 | Microbiology
Image: The acquisition adds the LEX VELO System to QuidelOrtho’s portfolio (photo courtesy of LEX Diagnostics)

QuidelOrtho Adds Ultra-Fast PCR Platform with LEX Acquisition

QuidelOrtho Corporation has completed the acquisition of LEX Diagnostics for approximately USD 100 million in cash. Read more
21 Apr 2026 | Industry
Image: New findings show data that multiple antibiotic resistance genes can be detected in newborns within hours of birth (photo credit: 123RF)

Antibiotic Resistance Genes Found in Newborns Within Hours of Birth

Antibiotic resistance in early life is challenging to characterize, particularly around the timing and drivers of gene acquisition in newborns. Read more
21 Apr 2026 | Microbiology
Image: Cancerguard is designed to detect multiple, including highly aggressive, cancers at early stages from a single blood draw (photo courtesy of Abbott)

Multi-Biomarker Blood Test Detects Early-Stage Cancers Across Types

Abbott is showcasing its Cancerguard multi-cancer early detection (MCED) test at the American Association for Cancer Research (AACR) Annual Meeting 2026, where new data highlight continued progress in the multi-biomarker program supporting the assay. Read more
21 Apr 2026 | Molecular Diagnostics
Image: MyGenius PRO installed at a leading European transplant center supporting routine infectious disease testing (photo courtesy of Bruker)

New Sample-to-Answer PCR System Supports High-Throughput Infectious Disease Testing

Clinical laboratories face mounting demand for rapid, high‑volume molecular testing for infectious diseases, including routine monitoring in immunocompromised patients. Read more
21 Apr 2026 | Molecular Diagnostics
Image: Seegene is presenting its data-driven diagnostics and automation strategy centered on STAgora and CURECA at ESCMID Global 2026 (photo courtesy of Seegene)

Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID

Seegene introduced STAgora, a real-time data analytics platform built on aggregated statistical testing data, at ESCMID Global 2026 in Munich, where it also presented an enhanced model of its automated PCR workflow concept CURECA. Read more
21 Apr 2026 | Industry
Image: Graphical abstract - Human immune aging clock identifies RUNX1 as a decelerator of T cell senescence (photo courtesy of Zhang Weiqi)

Immune Aging Clock Quantifies Immunosenescence and Identifies Therapeutic Target

Immune aging undermines host defense and contributes to multiple age-related diseases, yet its heterogeneity complicates measurement and intervention. Read more
20 Apr 2026 | Immunology
Image: Cancer hallmarks, molecular classes of iCCA, and therapies (Josep M. Llovet et al, Cell (2026). DOI: 10.1016/j.cell.2026.03.001)

Framework Guides Targeted Immunotherapy Selection in Liver Cancer

Primary liver cancer, encompassing hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA), is the world’s third-leading cause of cancer-related death, responsible for about 830,000 deaths and nearly one million new cases each year. Read more
20 Apr 2026 | Molecular Diagnostics
Image: Visby Medical’s Women’s Sexual Health PCR test is an FDA-authorized palm-sized device that reports results within 30 minutes via Visby’s mobile app (photo courtesy of Visby Medical)

Collaboration Brings Rapid At-Home STI Testing with Virtual Follow-Up

Sexually transmitted infections (STIs) are often asymptomatic, and reliance on clinic-based testing can delay diagnosis and treatment. Read more
20 Apr 2026 | Molecular Diagnostics
Image: Laboratories can access Waiv’s tests via the Destra platform or integrate them into existing workflows through compatible IMS and viewer systems (photo courtesy of Waiv)

AI Precision Tests Deliver Cancer Risk Insights from Routine H&E Slides

Reliable prognostic profiling and biomarker screening are essential to guide oncology treatment decisions, while laboratories must balance speed and resource constraints. Read more
20 Apr 2026 | Pathology
Image: Delve Detect applies mNGS to cerebrospinal fluid to identify clinically actionable pathogens beyond what current standard-of-care testing can provide (photo courtesy of Delve Bio)

mNGS CSF Test Identifies CNS Pathogens Missed by Standard Panels

Central nervous system (CNS) infections such as encephalitis, ventriculitis, and brain abscess are among the most time-sensitive diagnostic challenges in neurology. Read more
20 Apr 2026 | Microbiology
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease (MRD) platform. Read more
20 Apr 2026 | Industry
Image: Immunofluorescence staining showing that overexpression of WWOX (green) in A431 cells is associated with increased levels of p63 (red) (photo courtesy of Tirza Bidnay-Mizrahi)

Study Reveals Moleclar Mechanism Driving Aggressive Skin Cancer

Cutaneous squamous cell carcinoma (cSCC) is the world’s second most common skin cancer, and while many cases are treatable, a subset becomes highly aggressive and therapy‑resistant. Read more
20 Apr 2026 | Pathology
Image: Professor Rajesh Ramanathan, from the Sir Ian Potter NanoBioSensing Facility and NanoBiotechnology Research Laboratory in RMIT’s School of Science, and Dr Pabudi Weerathunge examine colour changes during a laboratory test used to identify golden staph strains (photo courtesy of Will Wright, RMIT University)

Rapid Color Test Stratifies Virulent and Resistant Staph Strains

Staphylococcus aureus (golden staph) remains a leading cause of infection-related mortality worldwide, responsible for more than a million deaths each year. Read more
18 Apr 2026 | Microbiology

Channels

Clinical Chemistry

view channel
Study Finds ApoB Testing More Effective Than LDL for Guiding Lipid Therapy
AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers
Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and...
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Molecular Diagnostics

view channel
Host–Virus Genetic Interactions Drive Nasopharyngeal Cancer Risk
AI-Enabled Biochip Detects microRNA Biomarkers in Minutes
Blood Test Detects Early Pancreatic Cancer in High-Risk Patients
Image: A new cfDNA epigenetic assay correlates with osteosarcoma status, supporting blood-based monitoring when ctDNA is scarce (photo courtesy of 123RF)

Blood-Based Epigenetic Signals Enable Osteosarcoma Disease Monitoring

Osteosarcoma is a rare but aggressive pediatric bone cancer where recurrence and metastasis remain difficult to detect early. Imaging-based surveillance can miss small lesions and exposes children to repeated... Read more

Hematology

view channel
Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy
Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
Image: The findings suggest anemia may signal underlying disease, with routine blood tests helping identify patients needing closer follow-up (photo courtesy of 123RF)

Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality

Anemia detected in routine care can signal underlying pathology and is frequently encountered in adults. Because it is defined by hemoglobin levels below the normal range, it is often evaluated with red... Read more

Immunology

view channel
Combined Screening Approach Identifies Early Leprosy Cases
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Car...
Image: The results indicate that routine clinical surveillance underestimates influenza’s contribution to winter deaths (photo courtesy of Adobe Stocks)

Study Finds Influenza Often Undiagnosed in Winter Deaths

Seasonal influenza drives substantial excess mortality, yet its contribution is often obscured when infections go undiagnosed near the time of death. Many deaths occur outside hospitals or in older adults... Read more

Microbiology

view channel
RNA-Based Workflow Identifies Active Skin Microbes for Dermatology Research
Cost-Effective Sampling and Sequencing Workflow Identifies ICU Infection Hotspot...
New Bacterial Target Identified for Early Detection of Noma
Image: The CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel identifies 20 gram-positive bacterial and fungal targets and 10 antimicrobial resistance markers directly from positive blood cultures and colonies in about one hour (photo courtesy of Adobe Stock)

Syndromic Panel Enables Rapid Identification of Bloodstream Infections

Bloodstream infections require rapid identification of causative pathogens and resistance determinants to guide therapy, yet laboratories often face pressure to deliver clinically relevant results quickly... Read more

Pathology

view channel
Collaboration Applies AI Pathology to Predict Response to Antibody-Drug Conjugat...
AI Improves Completeness of Complex Cancer Pathology Reports
AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer
Image: Eduard Batlle and Elena Sancho, ICB researchers and study authors (photo courtesy of Institute for Research in Biomedicine)

Biomarker Predicts Immunotherapy Response and Prognosis in Colorectal Cancer

Colorectal cancer is common and often lethal, and therapeutic decision-making is complicated by heterogeneous tumor microenvironments. Immunotherapy benefits only a small subset of patients, around 5%,... Read more

Technology

view channel
Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
Noninvasive Sputum Test Detects Early Lung Cancer
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Image: Flow chart summarizing workflow pipeline (Thomas, V., Nyamundanda, G., Lärkeryd, A. et al. Sci Rep 16, 8843 (2026). https://doi.org/10.1038/s41598-026-39189-w)

AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer

Advanced bowel cancer remains difficult to treat, and many patients receive targeted therapies that do not help them but still cause harm. Clinicians need reliable ways to identify likely responders before... Read more

Industry

view channel
QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026
Beckman Coulter Gains CE Mark for Rapid Assay Distinguishing Bacterial vs Viral ...
Junction, GRAIL Enable Scalable Access to Multi-Cancer Detection Test
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica ADLM

 

Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE